Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma

Statistics

Case Reports

Tratamiento neoadyuvante con acitretino oral e imiquimod tópico en el carcinoma basocelular gigante

V. Sanmartín

Corresponding author

vsanmartin6@yahoo.es

Corresponding author.

, R. Aguayo, M. Baradad, J.M. Casanova

Departamento de Dermatología, Hospital Arnau de Vilanova, Lleida, Spain

Read

11001

Times
was read the article

2471

Total PDF

8530

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2012.03.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 May	3	7	10
2024 April	107	28	135
2024 March	81	33	114
2024 February	75	26	101
2024 January	63	51	114
2023 December	84	20	104
2023 November	64	33	97
2023 October	73	27	100
2023 September	75	35	110
2023 August	71	20	91
2023 July	102	42	144
2023 June	83	21	104
2023 May	135	30	165
2023 April	113	15	128
2023 March	156	26	182
2023 February	156	29	185
2023 January	113	19	132
2022 December	89	43	132
2022 November	70	36	106
2022 October	65	18	83
2022 September	55	29	84
2022 August	25	21	46
2022 July	56	46	102
2022 June	58	35	93
2022 May	113	32	145
2022 April	127	45	172
2022 March	119	71	190
2022 February	92	32	124
2022 January	94	45	139
2021 December	55	44	99
2021 November	80	49	129
2021 October	331	53	384
2021 September	52	45	97
2021 August	58	28	86
2021 July	60	30	90
2021 June	52	36	88
2021 May	57	51	108
2021 April	143	43	186
2021 March	92	31	123
2021 February	59	19	78
2021 January	68	24	92
2020 December	64	28	92
2020 November	30	20	50
2020 October	60	21	81
2020 September	61	17	78
2020 August	41	25	66
2020 July	43	33	76
2020 June	49	26	75
2020 May	34	36	70
2020 April	32	28	60
2020 March	51	20	71
2020 February	8	3	11
2020 January	0	2	2
2019 December	4	2	6
2019 November	0	2	2
2019 October	0	4	4
2019 September	5	0	5
2019 August	0	2	2
2019 July	2	10	12
2019 June	10	19	29
2019 May	0	28	28
2019 April	9	22	31
2019 March	3	6	9
2019 February	3	4	7
2019 January	2	0	2
2018 December	4	0	4
2018 November	4	0	4
2018 October	19	0	19
2018 September	2	0	2
2018 April	0	2	2
2018 March	12	0	12
2018 February	108	4	112
2018 January	130	10	140
2017 December	110	12	122
2017 November	113	5	118
2017 October	113	10	123
2017 September	98	6	104
2017 August	119	11	130
2017 July	74	13	87
2017 June	94	25	119
2017 May	79	6	85
2017 April	80	10	90
2017 March	56	18	74
2017 February	50	9	59
2017 January	56	5	61
2016 December	119	16	135
2016 November	228	15	243
2016 October	257	23	280
2016 September	180	12	192
2016 August	194	18	212
2016 July	145	18	163
2016 June	11	9	20
2016 May	13	12	25
2016 April	6	6	12
2016 March	13	3	16
2016 February	8	6	14
2016 January	13	9	22
2015 December	11	11	22
2015 November	9	1	10
2015 October	14	4	18
2015 September	4	3	7
2015 August	14	5	19
2015 July	183	11	194
2015 June	79	10	89
2015 May	108	12	120
2015 April	113	15	128
2015 March	97	16	113
2015 February	96	8	104
2015 January	74	16	90
2014 December	89	10	99
2014 November	67	16	83
2014 October	82	12	94
2014 September	62	15	77
2014 August	95	17	112
2014 July	90	17	107
2014 June	96	18	114
2014 May	76	14	90
2014 April	55	12	67
2014 March	62	25	87
2014 February	24	8	32
2014 January	21	7	28
2013 December	42	13	55
2013 November	18	13	31
2013 October	18	15	33
2013 September	12	10	22
2013 August	7	22	29
2013 July	7	22	29
2013 June	7	31	38
2013 May	9	9	18
2013 April	13	13	26
2013 March	18	4	22
2013 February	34	3	37
2013 January	56	4	60
2012 December	23	7	30
2012 November	1	2	3
2012 October	1	1	2

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter